Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by M101


PMN

RE:How do you put people on ignore?

Biden would know, or used to before his dementia, either way really. 

March 3, 2022

PMN

chance for redemption?

Will Gene bet our brand marketing on another lame horse? https://endpts.com...

March 3, 2022

PMN

RE:RE:RE:RE:Talking Down Good News

FarmerBetty wrote: No disdain just stating facts, they have been doing mouse...

March 2, 2022

PMN

RE:Talking Down Good News

bball67 wrote: . The Company believes that these results were significant...

March 2, 2022

PMN

RE:RE:RE:RE:RE:PMN310 antibody demonstrates significant cognitive benefit .

And given the incredible scrutiny aducanumab's numbers eventually faced...

March 2, 2022

PMN

RE:RE:RE:PMN310 antibody demonstrates significant cognitive benefit .

Exactly, so what were the numbers? Maze readouts are usually time meaurements...

March 2, 2022

PMN

RE:PMN310 antibody demonstrates significant cognitive benefit .

"showed a significant cognitive benefit in a widely recognized animal...

March 2, 2022

PMN

RE:RE:abbvie antes up

By itself, nothing. Abbvie seems to like keeping a toe in the water, nothing...

March 1, 2022

PMN

abbvie antes up

Is this the start of some sector pipeline construction? https://endpts.com...

March 1, 2022

PMN

RE:RE:RE:Alzheon

to be a fly on the wall...

February 28, 2022

PMN

RE:Alzheon

Speyeder999 wrote: WOW!... I'd like to see Cashman et al mention...

February 27, 2022

PMN

RE:Alzheon

lot's to like there, thanks I wasn't betting on Tramisprosate but...

February 25, 2022

PMN

RE:Slow Year for Press Releases

Not a chance. Goldstein took heat here for unwarranted PR but PMN has...

February 24, 2022

PMN

RE:RE:RE:class war

Gbathat wrote: Probably because the bigger companies are not offering what...

February 22, 2022

PMN

RE:RE:RE:RE:class war

Let's not confuse insight with opinion. Your question got me to browse...

February 21, 2022

PMN

RE:RE:class war

azzymaa wrote: why doesn't pmn just get bought out by a bigger company if...

February 19, 2022

PMN

class war

Why does Promis promote the idea that 310 is in the same class as aducanumab?...

February 19, 2022

PMN

RE:RE:RE:From Promis's Facebook page a few days ago

He does make a lot of sense, so does MSM. I get blank stares like yours from...

February 18, 2022

PMN

RE:RE:From Promis's Facebook page a few days ago

Ok, here's your blindspot RC: Promis shareholders are asked to believe...

February 18, 2022

PMN

RE:From Promis's Facebook page a few days ago

Nebulous statements like that have always been in the presentations, but...

February 17, 2022

Featured Company